Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can acupuncture frequencies unlock swallowing after stroke?

NCT ID NCT07496762

Symptom relief Sponsor: Kaili Chen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether different frequencies of electroacupuncture (low, medium, or high) can improve swallowing problems in 90 stroke survivors. Participants will receive daily 30-minute sessions over several weeks. The goal is to find the best frequency and understand how it affects brain pathways involved in swallowing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
electroacupuncture (low, medium, or high frequency)
What this could lead to
If successful, this could identify the most effective electroacupuncture frequency to help stroke survivors regain swallowing ability.
What could go wrong
This is an early-stage study with no placebo group, so results may not prove effectiveness. The treatment is also not a cure for the underlying stroke damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis: Patients diagnosed with cerebral infarction confirmed by CT or MRI. * Dysphagia Screening: Presence of varying degrees of dysphagia as screened by the Water Swallow Test (WST). * Clinical Status: Conscious and stable vital signs, with the ability to cooperate with the treatment. * Age: Aged between 18 and 80 years. * Consent: Signed informed consent form obtained from the patient or their legal representative. Exclusion Criteria: * Dysphagia Etiology: Patients with dysphagia caused by etiologies other than cerebral infarction. * MRI Contraindications: Patients with metal implants or pacemakers in the body (contraindications for MRI). * Bleeding Risk: Patients with bleeding tendencies or coagulation disorders. * Blood Pressure: Patients with uncontrolled hypertension (systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 120 mmHg). * Organ Failure: Patients with severe failure of vital organs (e.g., heart, liver, or kidney failure). * Disease Severity: Patients with critical or life-threatening stroke conditions. * Cooperation: Patients unable to cooperate with the treatment due to severe cognitive impairment, aphasia, or other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acupuncture therapy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral infarction Deglutition Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acupuncture therapy Deglutition disorders Electroacupuncture Stroke sequelae

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • the Third Affiliated Hospital of Zhejiang Chinese Medical University

    Hangzhou, Zhejiang, 310000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.